Market Overview

Sanofi: Debt Insights


Shares of Sanofi (NASDAQ: SNY) rose by 0.17% in the past three months. Before having a look at the importance of debt, let us look at how much debt Sanofi has.

Sanofi's Debt

Based on Sanofi’s balance sheet as of March 5, 2020, long-term debt is at $22.60 billion and current debt is at $5.11 billion, amounting to $27.71 billion in total debt. Adjusted for $10.58 billion in cash-equivalents, the company's net debt is at $17.13 billion.

Shareholders look at the debt-ratio to understand how much financial leverage a company has. Sanofi has $126.57 billion in total assets, therefore making the debt-ratio 0.22. Generally speaking, a debt-ratio more than one means that a large portion of debt is funded by assets. As the debt-ratio increases, so the does the risk of defaulting on loans, if interest rates were to increase. Different industries have different thresholds of tolerance for debt-ratios. A debt ratio of 35% might be higher for one industry and average for another.

Importance Of Debt

Besides equity, debt is an important factor in the capital structure of a company, and contributes to its growth. Due to its lower financing cost compared to equity, it becomes an attractive option for executives trying to raise capital.

However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations.


Related Articles (SNY)

View Comments and Join the Discussion!

Posted-In: Debt InsightsNews Intraday Update Markets